NCT07003503

Brief Summary

This study aims to investigate the current situation and risk factors of adverse mental disorders in pregnant women with hyperglycemia. it could include any of the following: 18-45 years old pregnant women with hyperglycemia. The main question is to answer the risk factor for antenatal mental disorder. participants need to complete a self-report questionnaire.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
635

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jun 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Jun 2025Dec 2026

First Submitted

Initial submission to the registry

April 22, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

June 30, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

April 22, 2025

Last Update Submit

May 26, 2025

Conditions

Keywords

hyperglycemiaantenatal mental disorderpregnancy complication

Outcome Measures

Primary Outcomes (1)

  • patient health questionnaire -9 (PHQ-9) score

    In the first, second and third trimesters, due to the government's policy, all pregnancies need to complete a EDSS if they want. When the pregnancies were diagnosed with hyperglycemia, a consent form was sent to them. After getting consent from them, researchers will retrospectively collect their medical records and EDSS scores in the government system when the participants were administrated in hospital to deliver the baby. the interpretation of PHQ-9: Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.

    Participants were administered in the hospital to deliver the baby.

Secondary Outcomes (1)

  • Generalized Anxiety Disorder-7 scale score (GAD-7)

    Participants were administered in the hospital to deliver the baby.

Study Arms (1)

pregnant women with hyperglycemia

Inclusion criteria: ① Pregnant women were confirmed as having gestational diabetes through biochemical examinations and glucose tolerance tests, etc. ② Possess the abilities of listening, speaking, reading, writing and comprehension, and be capable of effective communication; ③ Age: 18-45 years old (including 18 and 45 years old); ④ Informed consent and voluntary participation in the research; ⑤ Gestational age: 28 to 37 weeks (including 28 weeks but excluding 37 weeks). Exclusion criteria: ① Abnormal fetuses and multiple pregnancies; ② Other pregnancy complications and comorbidities, such as heart disease, preeclampsia, liver disease, etc. ③ There is a history of mental illness or mental disorders in the past. ④ Those who are unable to communicate effectively by using listening, speaking, reading and writing skills; ⑤ Patients with diabetes mellitus complicated with pregnancy; ⑥ Those who use psychotropic or neurotropic drugs.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants should follow inclusive and exclusive criteria.

You may qualify if:

  • The pregnant woman was confirmed to have gestational diabetes through biochemical tests and glucose tolerance tests, etc.
  • Possess the abilities of listening, speaking, reading, writing and comprehension, and be capable of effective communication;
  • Age: 18-45 years old (including 18 and 45 years old);
  • informed consent and voluntary participation in the research;
  • Gestational age: 28 to 37 weeks (including 28 weeks but excluding 37 weeks).

You may not qualify if:

  • Abnormal fetuses, multiple pregnancies;
  • Other pregnancy complications and comorbidities, such as heart disease, preeclampsia, liver disease, etc.
  • There is a history of mental illness or mental disorders in the past.
  • Those who are unable to communicate effectively by using listening, speaking, reading and writing skills;
  • Patients with diabetes mellitus complicated with pregnancy;
  • Those who use psychotropic or neurotropic drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (8)

  • Delanerolle G, Phiri P, Zeng Y, Marston K, Tempest N, Busuulwa P, Shetty A, Goodison W, Muniraman H, Duffy G, Elliot K, Maclean A, Majumder K, Hirsch M, Rathod S, Raymont V, Shi JQ, Hapangama DK. A systematic review and meta-analysis of gestational diabetes mellitus and mental health among BAME populations. EClinicalMedicine. 2021 Jul 14;38:101016. doi: 10.1016/j.eclinm.2021.101016. eCollection 2021 Aug.

    PMID: 34308317BACKGROUND
  • DOI:10.16766/j.cnki.issn.1674-4152.003467.

    BACKGROUND
  • Thiele GA, Ryan DM, Oberlander TF, Hanley GE. Preconception mental health and the relationship between antenatal depression or anxiety and gestational diabetes mellitus: a population-based cohort study. BMC Pregnancy Childbirth. 2022 Aug 31;22(1):670. doi: 10.1186/s12884-022-05002-5.

    PMID: 36045319BACKGROUND
  • Schmitt A, Bendig E, Baumeister H, Hermanns N, Kulzer B. Associations of depression and diabetes distress with self-management behavior and glycemic control. Health Psychol. 2021 Feb;40(2):113-124. doi: 10.1037/hea0001037. Epub 2020 Nov 30.

    PMID: 33252963BACKGROUND
  • Riggin L. Association Between Gestational Diabetes and Mental Illness. Can J Diabetes. 2020 Aug;44(6):566-571.e3. doi: 10.1016/j.jcjd.2020.06.014. Epub 2020 Jun 22.

    PMID: 32792108BACKGROUND
  • https://www.mdpi.com/1660-4601/17/11/3767.

    BACKGROUND
  • Mazumder T, Akter E, Rahman SM, Islam MT, Talukder MR. Prevalence and Risk Factors of Gestational Diabetes Mellitus in Bangladesh: Findings from Demographic Health Survey 2017-2018. Int J Environ Res Public Health. 2022 Feb 23;19(5):2583. doi: 10.3390/ijerph19052583.

    PMID: 35270274BACKGROUND
  • Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022 May 25;377:e067946. doi: 10.1136/bmj-2021-067946.

    PMID: 35613728BACKGROUND

MeSH Terms

Conditions

HyperglycemiaMental DisordersPregnancy Complications

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

zonglian guo, master

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

April 22, 2025

First Posted

June 4, 2025

Study Start

June 30, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

June 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

protocol

Shared Documents
STUDY PROTOCOL